Tag Archives: EU

Who Dares to Stop the European Transparency Bandwagon?

Who is Trying to Stop the European Transparency Bandwagon? Reflector, EPE, October 14 2013 The data-transparency bandwagon is rolling rapidly across Europe, energetically propelled by regulators, health campaigners, and generic manufacturers. Much of the research-based industry is stepping out of the way of what looks like an unstoppable juggernaut, hoping at best to nudge it […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , | Leave a comment

Shutdown Stalls US–EU Trade Agreement Talks

Another temporary casualty of the US government shutdown are the negotiations surrounding the US and Europe’s mooted free trade agreement. The second round of the Transatlantic Trade and Investment Partnership (T-TIP) talks were due to start this week in Brussels, Belgium, but following last Tuesday’s closedown of non-essential US operations, trade representative Michael Froman told […]
Posted in Europe, Global | Also tagged , , , | Leave a comment

Europe's Bioscience 'Oscars': The Contenders

By Peter O’ Donnell. Europe’s closest thing to an Oscar’s ceremony for bioscience will take place in early October. The EuropaBio award for the most innovative European Union biotechnology firm is limited to firms with fewer than 250 staff or turnover or balance sheet of less than about $50 million. The aim is to encourage […]
Posted in Europe, Global, Guest Blog | Also tagged , , | Leave a comment

Europe: Still An Attractive Place for Clinical Trials?

At the end of this month, the European Medicines Agency will close the consultation on its draft policy on Publication and access to clinical-trial data. The aim of the policy is laudable: to open up as much information as possible into the public domain with the aim of stimulating new avenues of research. So far […]
Posted in Europe, Op-Ed, R&D | Also tagged , , , | 1 Comment

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

EuropeNew Device and Diagnostics Legislation Will Shake Up Drug Industry The shockwaves from the current European Union debates in Brussels on medical devices are are likely to echo through the medicines business over the next few years. This month, the European parliament’s health committee will reach its view on the two major proposals launched last […]
Posted in Europe, Op-Ed, Regulatory | Also tagged , , , | 1 Comment
  • Categories

  • Meta